---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-23-000063"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-12T00:06:02.859433+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Chief Scientific and Operating Officer Dr. Ryan Phan resigns effective Sep 15, 2023

## Summary
- Dr. Ryan Phan resigns as Chief Scientific and Operating Officer effective September 15, 2023.
- Company expects to enter into an advisory agreement with Dr. Phan for ongoing product development.
- No successor has been announced for the CSO and COO role.

## SEC filing metadata
- accession: 0000926617-23-000063
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661723000063/0000926617-23-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661723000063/awh-20230803x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-23-000063
- JSON: https://secwatch.observer/filing/0000926617-23-000063.json
- Plain text: https://secwatch.observer/filing/0000926617-23-000063.txt

## Key facts
- Executive change
  Dr. Ryan Phan resigned as Chief Scientific and Operating Officer at Aspira Women's Health Inc..
  - Action: resigned
  - Role: Chief Scientific and Operating Officer
  source text: On August 3, 2023, Dr. Ryan Phan notified Aspira Women’s Health Inc., (the “Company”), of his intent to resign as Chief Scientific and Operating Officer of the Company effective September 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000063/0000926617-23-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.